Stage I Gastric Cancer AJCC V7

specific

Stage II includes: IIA (T3, N0, M0); (T2, N1, M0); (T1, N2, M0); IIB (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. T4a: Tumor invades serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastas

32

Centers

32

Active Trials

Cancer Funding

Top Centers for Stage I Gastric Cancer AJCC V7(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.6
2
NCI Comprehensive
Active Research Program
51.6
3
NCI Comprehensive
Active Research Program
51.6
4
NCI Comprehensive
Active Research Program
51.6
551.6
6
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.6
7
NCI Comprehensive
Active Research Program
51.6
8
NCI Comprehensive
Active Research Program
51.6
9
NCI Comprehensive
Active Research Program
51.6
10
NCI Comprehensive
Active Research Program
51.6
11
NCI Clinical
Active Research Program
51.6
12
NCI Comprehensive
Active Research Program
51.6
13
Active Research Program
51.6
14
NCI Comprehensive
Active Research Program
51.6
15
NCI Clinical
Active Research Program
51.6
16
NCI Comprehensive
Active Research Program
51.6
17
Active Research Program
51.6
18
NCI Comprehensive
Active Research Program
51.6
19
Active Research Program
51.6
2051.6
21
Active Research Program
51.6
22
Active Research Program
51.6
23
Active Research Program
51.6
24
Active Research Program
51.6
25
Active Research Program
51.6
26
Active Research Program
51.6
27
Active Research Program
51.6
28
Active Research Program
51.6
29
Active Research Program
51.6
30
Active Research Program
51.6
31
Active Research Program
51.6
32
Active Research Program
51.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →